Key Points
- CEO George Lemaitre sold 55,930 shares at an average price of $107.81 for proceeds of $6,029,813.30, reducing his ownership by 3.65% to 1,476,500 shares (SEC filing).
- Dividend increase and buyback announced: the company raised its quarterly dividend to $0.25 (annualized $1.00, yield ~0.9%) and disclosed a share buyback, with the ex-dividend date on March 12 and payment on March 26.
- LeMaitre beat Q4 estimates with $0.68 EPS on $64.45M revenue (up 15.7% YoY) and gave FY2026 guidance of $2.81–$3.01 EPS, while analysts maintain a consensus "Hold" rating and an average target of $105.80.
LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) insider Trent Kamke sold 1,044 shares of LeMaitre Vascular stock in a transaction on Friday, February 27th. The stock was sold at an average price of $110.29, for a total value of $115,142.76. Following the sale, the insider directly owned 6,677 shares of the company's stock, valued at $736,406.33. This represents a 13.52% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
LeMaitre Vascular Price Performance
NASDAQ:LMAT opened at $107.39 on Tuesday. LeMaitre Vascular, Inc. has a 52 week low of $71.42 and a 52 week high of $115.33. The company has a debt-to-equity ratio of 0.43, a quick ratio of 10.95 and a current ratio of 12.89. The firm's 50-day simple moving average is $87.47 and its 200 day simple moving average is $88.40. The firm has a market cap of $2.45 billion, a price-to-earnings ratio of 42.78, a P/E/G ratio of 2.01 and a beta of 0.66.
LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The medical instruments supplier reported $0.68 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.67 by $0.01. LeMaitre Vascular had a net margin of 23.13% and a return on equity of 14.72%. The firm had revenue of $64.45 million during the quarter, compared to the consensus estimate of $62.98 million. During the same quarter in the previous year, the firm posted $0.49 EPS. The business's revenue for the quarter was up 15.7% compared to the same quarter last year. LeMaitre Vascular has set its FY 2026 guidance at 2.810-3.010 EPS and its Q1 2026 guidance at 0.640-0.690 EPS. As a group, sell-side analysts predict that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.
LeMaitre Vascular Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Thursday, March 12th will be paid a dividend of $0.25 per share. This is a boost from LeMaitre Vascular's previous quarterly dividend of $0.20. The ex-dividend date is Thursday, March 12th. This represents a $1.00 dividend on an annualized basis and a yield of 0.9%. LeMaitre Vascular's dividend payout ratio is 31.87%.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on LMAT shares. Weiss Ratings cut LeMaitre Vascular from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Tuesday, February 24th. Roth Mkm reissued a "buy" rating and issued a $117.00 target price (up from $108.00) on shares of LeMaitre Vascular in a report on Thursday, February 26th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $95.00 price target on shares of LeMaitre Vascular in a report on Monday, November 10th. Wall Street Zen upgraded shares of LeMaitre Vascular from a "hold" rating to a "buy" rating in a research report on Saturday, February 21st. Finally, Citizens Jmp boosted their price objective on shares of LeMaitre Vascular from $113.00 to $118.00 and gave the company a "market outperform" rating in a research report on Thursday, February 26th. Three equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $105.80.
View Our Latest Research Report on LMAT
Hedge Funds Weigh In On LeMaitre Vascular
A number of institutional investors have recently added to or reduced their stakes in LMAT. Parkside Financial Bank & Trust lifted its stake in LeMaitre Vascular by 1,913.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 302 shares of the medical instruments supplier's stock valued at $25,000 after purchasing an additional 287 shares during the last quarter. Cornerstone Planning Group LLC increased its holdings in shares of LeMaitre Vascular by 534.0% during the third quarter. Cornerstone Planning Group LLC now owns 336 shares of the medical instruments supplier's stock worth $30,000 after buying an additional 283 shares in the last quarter. MAI Capital Management bought a new position in shares of LeMaitre Vascular in the 3rd quarter valued at $38,000. First Horizon Corp bought a new position in shares of LeMaitre Vascular in the 3rd quarter valued at $39,000. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of LeMaitre Vascular by 250.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 557 shares of the medical instruments supplier's stock valued at $47,000 after acquiring an additional 398 shares in the last quarter. 84.64% of the stock is currently owned by institutional investors and hedge funds.
Trending Headlines about LeMaitre Vascular
Here are the key news stories impacting LeMaitre Vascular this week:
LeMaitre Vascular Company Profile
(
Get Free Report)
LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company's offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre's product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.
Founded in 1983 by George D.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
